Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2618

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2618
---
 rights;

    ●
    we
    or our licensors, as the case may be, might not have been the first to file patent applications for these inventions;

    ●
    others
    may independently develop similar or alternative technologies or duplicate any of our technologies;

    ●
    it
    is possible that our pending patent applications will not result in issued patents;

    ●
    it
    is possible that there are prior public disclosures that could invalidate our or our licensors’ patents, as the case may be,
    or parts of our or their patents;

    ●
    it
    is possible that others may circumvent our owned or in-licensed patents;

    ●
    it
    is possible that there are unpublished applications or patent applications maintained in secrecy that may later issue with claims
    covering our products or technology similar to ours;

    ●
    the
    laws of foreign countries may not protect our or our licensors’, as the case may be, proprietary rights to the same extent
    as the laws of the United States;

    ●
    the
    claims of our owned or in-licensed issued patents or patent applications, if and when issued, may not cover our product candidates;

    ●
    our
    owned or in-licensed issued patents may not provide us with any competitive advantages, may be narrowed in scope, or be held invalid
    or unenforceable as a result of legal challenges by third parties;

    ●
    the
    inventors of our owned or in-licensed patents or patent applications may become involved with competitors, develop products or processes
    which design around our patents, or become hostile to us or the patents or patent applications on which they are named as inventors;

96

    ●
    it
    is possible that our owned or in-licensed patents or patent applications omit individual(s) that should be listed as inventor(s)
    or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent
    applications to be held invalid or unenforceable;

    ●
    we
    have engaged in scientific collaborations in the past and will continue to do so in the future. Such collaborators may develop adjacent
    or competing products to ours that are outside the scope of our patents;

    ●
    we
    may not develop additional proprietary technologies for which we can obtain patent protection;

    ●
    it
    is possible that product candidates or diagnostic tests we